News
Fintiv, Inc. has filed a complaint against Apple, Inc. in the U.S. District Court for the Northern District of Georgia, ...
Today, the CAFC issued a ruling vacating a final written decision by the Patent Trial and Appeal Board that invalidated ...
Pharmaceutical companies were dealt back-to-back blows over the last 24 hours in their fight against the Biden-era Medicare Drug Price Negotiation Program, which the Trump Administration has continued ...
The U.S. Court of Appeals for the Tenth Circuit on Tuesday partially reversed and remanded a district court decision granting ...
In the latest development on USPTO Director Coke Morgan Stewart’s “settled expectations” doctrine, Stewart today denied ...
Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...
The Council for Innovation Promotion (C4IP) today issued a statement taking Congress to task for supporting a bill introduced ...
Our conversation this week is about PTAB practice and how it has evolved over the last several months; we specifically ...
Last week, reports surfaced that spokespeople from the European Commission had confirmed the official withdrawal of ...
On Friday, August 1, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential ruling in FMC Corp. v.
Thank you for inviting Senator Tillis’ office to participate in this listening session. Panelists were asked to address an issue impacting drug affordability and accessibility. I appreciate the ...
The Wall Street Journal is reporting that the Trump Administration is considering a major change to patent fees, which would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results